Low molecular weight heparin for thromboprophylaxis during caesarean section.
Bonnar
J
J
Department of Obstetrics and Gynaecology, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland. jbonnar@tcd.ie
Norris
L A
LA
Greene
R
R
D000328:Adult; D000906:Antibodies / Q000097:blood / Q000187:drug effects; D001777:Blood Coagulation / Q000187:drug effects; D002585:Cesarean Section / Q000009:adverse effects*; D036861:Delivery, Obstetric; D017984:Enoxaparin / Q000008:administration & dosage; D015951:Factor Xa / Q000276:immunology; D005260:Female; D005312:Fetal Blood / Q000276:immunology; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*; D013997:Time Factors; D016896:Treatment Outcome
D000906:Antibodies; D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight; D015951:Factor Xa